Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Shanghai - Delayed Quote CNY

Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)

Compare
94.11
-3.41
(-3.50%)
As of 11:29:53 AM GMT+8. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,206,326.73
1,206,326.73
1,187,204.46
896,500.38
684,630.75
Cost of Revenue
325,577.17
325,577.17
279,577.99
222,512.62
150,281.29
Gross Profit
880,749.56
880,749.56
907,626.46
673,987.77
534,349.46
Operating Expense
315,724.90
315,724.90
343,643.90
268,933.43
194,090.99
Operating Income
565,024.66
565,024.66
563,982.57
405,054.33
340,258.47
Net Non Operating Interest Income Expense
15,057.33
15,057.33
7,220.77
8,921.19
11,845.44
Pretax Income
652,193.92
652,193.92
572,266.99
413,895.42
361,660.17
Tax Provision
159,445.59
159,445.59
85,050.01
61,844.86
48,148.27
Net Income Common Stockholders
502,100.21
502,100.21
492,431.97
356,878.47
315,855.66
Basic EPS
4.07
4.07
6.81
3.33
2.95
Diluted EPS
4.07
4.07
6.81
3.33
2.95
Basic Average Shares
123,366.14
123,366.14
72,310.13
107,207.44
107,203.86
Diluted Average Shares
123,366.14
123,366.14
72,310.13
107,207.44
107,203.86
Total Operating Income as Reported
661,172.43
661,172.43
573,854.34
415,214.10
362,775.85
Rent Expense Supplemental
--
--
--
--
77.55
Total Expenses
641,302.07
641,302.07
623,221.89
491,446.05
344,372.28
Net Income from Continuing & Discontinued Operation
502,100.21
502,100.21
492,431.97
356,878.47
315,855.66
Normalized Income
508,077.15
508,077.15
498,979.51
361,013.31
319,240.53
Interest Income
17,090.47
17,090.47
9,261.27
11,252.78
13,776.19
Interest Expense
1,648.78
1,648.78
1,821.93
2,087.35
1,771.92
Net Interest Income
15,057.33
15,057.33
7,220.77
8,921.19
11,845.44
EBIT
653,842.70
653,842.70
574,088.91
415,982.77
363,432.09
EBITDA
703,848.13
703,848.13
609,359.30
449,153.91
387,142.78
Reconciled Cost of Revenue
325,577.17
325,577.17
279,577.99
222,512.62
150,281.29
Reconciled Depreciation
50,005.43
50,005.43
35,270.39
33,171.14
23,710.69
Net Income from Continuing Operation Net Minority Interest
502,100.21
502,100.21
492,431.97
356,878.47
315,855.66
Total Unusual Items Excluding Goodwill
-7,911
-7,911
-7,690.49
-4,861.21
-3,904.71
Total Unusual Items
-7,911
-7,911
-7,690.49
-4,861.21
-3,904.71
Normalized EBITDA
711,759.12
711,759.12
617,049.79
454,015.12
391,047.49
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,934.05
-1,934.05
-1,142.96
-726.37
-519.84
12/31/2021 - 7/22/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6922.HK Cryofocus Medtech (Shanghai) Co., Ltd.
4.200
-13.40%
 
9996.HK Peijia Medical Limited
4.450
-12.75%
 
2500.HK Venus Medtech (Hangzhou) Inc.
1.810
-19.20%
 
0853.HK MICROPORT
6.870
-11.13%
 
2252.HK Shanghai MicroPort MedBot (Group) Co., Ltd.
14.640
-11.70%
 
DRW3.DE Drägerwerk AG & Co. KGaA
60.30
-2.74%
 
EW Edwards Lifesciences Corporation
69.36
-4.96%
 
MDT Medtronic plc
82.88
-5.70%
 
BSX Boston Scientific Corporation
89.70
-8.93%